MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$1,989,333
EPS
-$0.09
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Research and development
1,285,942
1,118,649
993,066
1,387,275.25*
General and administrative
744,276
1,114,525
803,619
1,010,636*
Total operating expenses
2,030,218
2,233,174
1,796,685
2,397,911.25
Loss from operations
-2,030,218
-2,233,174
-1,796,685
-2,397,911.25*
Interest income
40,885
12,455
11,627
31,207*
Interest expense
-
-
-
37.25*
Other income, net
40,885
12,455
11,627
31,169.75*
Net loss
-1,989,333
-2,220,719
-1,785,058
-2,366,741.5
Basic EPS
-0.09
-0.11
-0.1
-0.157
Diluted EPS
-0.09
-0.11
-0.1
-0.157
Basic Average Shares
21,609,488
19,850,080
17,082,425
15,116,548
Diluted Average Shares
21,609,488
19,850,080
17,082,425
15,116,548
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Interest income
$40,885
Net loss
-$1,989,333
Other income, net
$40,885
Loss from operations
-$2,030,218
Total operating
expenses
$2,030,218
Research and development
$1,285,942
General and
administrative
$744,276
Buy us a coffee
NANOVIRICIDES, INC. (NNVC)
NANOVIRICIDES, INC. (NNVC)